ACCESS PACK EXPO XPRESS ONLINE TODAY
ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.
LEARN MORE

Incorrect Label Potency Leads to Thyroid Drug Recall

Acella Pharmaceuticals has recalled its thyroid medication for the third time in a year over potency issues.

A recent WebMD article discussed a nationwide thyroid drug recall linked to incorrect information on the label. The drug in question is Acella Pharmaceuticals’ NP Thyroid medication intended to treat hypothyroidism. During routine testing, the affected lots were found to contain less than 90% of the two ingredients listed on the label: liothyronine and levothyroxine.

At least 43 adverse events have been reported in relation to the drug, which could be linked to the recall. This is the third recall related to this particular drug’s potency in the past year. Back in November, the potency was too low, and last May it was overly potent. 

Access On-Demand Content Today
Discover innovative solutions for packaging and processing, automation, sustainability, e-commerce and more.
LEARN MORE
Access On-Demand Content Today
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub